Chevy Chase Trust
CRL icon

Chevy Chase Trust’s Charles River Laboratories CRL Stock Holding History

Chevy Chase Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.18M Sell
24,245
-707
-3% -$131K 0.01% 520
2025
Q4 		$4.98M Sell
24,952
-164
-0.7% -$29.7K 0.01% 517
2025
Q3 		$3.93M Sell
25,116
-827
-3% -$131K 0.01% 532
2025
Q2 		$3.94M Sell
25,943
-875
-3% -$117K 0.01% 533
2025
Q1 		$4.04M Sell
26,818
-16
-0.1% -$2.68K 0.01% 534
2024
Q4 		$4.95M Sell
26,834
-849
-3% -$164K 0.02% 510
2024
Q3 		$5.45M Sell
27,683
-447
-2% -$92.9K 0.02% 499
2024
Q2 		$5.81M Sell
28,130
-283
-1% -$64.1K 0.02% 479
2024
Q1 		$7.7M Sell
28,413
-242
-0.8% -$57.8K 0.03% 452
2023
Q4 		$6.77M Sell
28,655
-166
-0.6% -$32.6K 0.02% 463
2023
Q3 		$5.65M Sell
28,821
-624
-2% -$128K 0.02% 471
2023
Q2 		$6.19M Sell
29,445
-122
-0.4% -$24.3K 0.02% 472
2023
Q1 		$5.97M Buy
29,567
+303
+1% +$68.7K 0.02% 477
2022
Q4 		$6.38M Sell
29,264
-1,795
-6% -$392K 0.03% 462
2022
Q3 		$6.11M Buy
31,059
+377
+1% +$81.4K 0.03% 460
2022
Q2 		$6.57M Buy
30,682
+342
+1% +$83.6K 0.03% 463
2022
Q1 		$8.62M Buy
30,340
+43
+0.1% +$13.3K 0.03% 449
2021
Q4 		$11.4M Sell
30,297
-659
-2% -$256K 0.04% 392
2021
Q3 		$12.8M Sell
30,956
-1,078
-3% -$448K 0.04% 357
2021
Q2 		$11.8M Buy
+32,034
New +$10.7M 0.04% 385
2020
Q1 		– Sell
-593
Closed -$91K – 708
2019
Q4 		$91K Buy
+593
New +$82.1K ﹤0.01% 735

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Chevy Chase Trust's CRL Position: Q1 2026 in Review

Chevy Chase Trust reduced its Charles River Laboratories (CRL) stake by 2.8% in Q1 2026, selling an estimated $131K and leaving 24,245 shares worth $4.18M. The position accounts for 0.01% of the portfolio, ranked #520.

Chevy Chase Trust first reported a position in CRL in Q4 2019 and has held it in 21 quarters since. The position peaked at $12.8M in Q3 2021. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Chevy Chase Trust held 24,245 shares of Charles River Laboratories worth $4.18M as of Q1 2026.
  • Chevy Chase Trust sold 707 Charles River Laboratories shares in Q1 2026, an estimated $131K.
  • Charles River Laboratories made up 0.01% of Chevy Chase Trust's portfolio in Q1 2026, its #520 holding.
  • Chevy Chase Trust first reported a position in Charles River Laboratories in Q4 2019 and has held it in 21 quarters since.
  • Chevy Chase Trust's Charles River Laboratories position peaked at $12.8M in Q3 2021.
  • 558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Chevy Chase Trust's 13F filing for Q1 2026, filed 15 May 2026.